Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California.
MPH Illinois Eye and Ear Infirmary, University of Illinois College of Medicine at Chicago, Chicago, Illinois.
Ophthalmology. 2019 Oct;126(10):1454-1461. doi: 10.1016/j.ophtha.2019.05.009. Epub 2019 Jun 21.
To compare the visual outcomes and adverse events associated with optical correction using an intraocular lens (IOL), contact lenses, or spectacles after cataract surgery in children 2 years of age or younger.
Literature searches were conducted in PubMed, the Cochrane Library, and the databases of clinical trials in February 2019, without date or language restrictions. The search resulted in 194 potentially relevant citations, and 34 were selected for full-text review. Fourteen studies were determined to be relevant to the assessment criteria and were selected for inclusion in this assessment. The panel methodologist then assigned a level of evidence rating to these studies.
Intraocular lenses were associated with visual outcomes similar to outcomes for contact lenses or spectacles for children who had both bilateral and unilateral cataracts. Intraocular lenses were also associated with an increased risk of visual axis opacities. All treatments were associated with a similar incidence of glaucoma. Although ocular growth was similar for all treatments, infants younger than 6 months who underwent IOL implantation had large myopic shifts that often resulted in high myopia or severe anisometropia later in childhood. Corneal endothelial cell counts were lower in eyes that underwent IOL implantation. The incidence of strabismus was similar with all treatments.
Intraocular lens implantation is not recommended for children 6 months of age or younger because there is a higher incidence of visual axis opacities with this treatment compared with aphakia. The best available evidence suggests that IOL implantation can be done safely with acceptable side effects in children older than 6 months of age. However, the unpredictability of ocular growth means that these children will often have large refractive errors later in childhood that may necessitate an IOL exchange or wearing spectacles or contact lenses with a large refractive correction. In addition, the training and experience of the surgeon as well as ocular and systemic comorbidities should be taken into consideration when deciding whether IOL implantation would be appropriate.
比较儿童 2 岁及以下白内障手术后使用人工晶状体(IOL)、接触镜或眼镜进行光学矫正的视觉结果和不良事件。
2019 年 2 月,在 PubMed、Cochrane 图书馆和临床试验数据库中进行了文献检索,无日期和语言限制。搜索结果产生了 194 个潜在相关引文,其中 34 个被选为全文审查。14 项研究被认为符合评估标准,并被选为纳入本评估。小组方法学家随后对这些研究进行了证据水平评级。
对于双眼和单眼白内障患儿,IOL 的视觉结果与接触镜或眼镜相似。IOL 还与视觉轴混浊的风险增加有关。所有治疗方法都与相似的青光眼发病率有关。尽管所有治疗方法的眼球生长都相似,但 6 个月以下的婴儿植入 IOL 后会出现较大的近视漂移,这通常会导致后期高度近视或严重的屈光参差。植入 IOL 的眼睛的角膜内皮细胞计数较低。斜视的发生率与所有治疗方法相似。
不建议 6 个月或以下的儿童植入 IOL,因为与无晶状体相比,这种治疗方法的视觉轴混浊发生率更高。现有最佳证据表明,6 个月以上的儿童可以安全地进行 IOL 植入,且副作用可接受。然而,眼球生长的不可预测性意味着这些儿童在后期的童年时期往往会有较大的屈光不正,可能需要进行 IOL 更换或佩戴具有较大屈光矫正的眼镜或接触镜。此外,在决定是否植入 IOL 时,应考虑外科医生的培训和经验以及眼部和全身合并症。